- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 46.11M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $122.11M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $121.73M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $112.03M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $104.03M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $171.99M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $42M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $45.95M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $294.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $294.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $237.18M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $276.14M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $247.62M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $285.71M |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$31.74M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$40.13M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$65.21M |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.87 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $27.3M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $15.49M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$32.29M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$25.74M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $17.05M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.73M |
| Revenue | Q1 2025 · Mar 31, 2024 | $18.78M |